eMIMS on the desktop and in the cloud

MIMS has developed two delivery platforms for the new version of its eMIMS drug reference product, launching a cloud-based version this week with a desktop version to follow.

The new eMIMSCloud allows users to access the resource by key, click or touch on a PC or Mac desktop or laptop or Android tablet. It is supported in Internet Explorer, Firefox, Safari and Chrome.

It contains current Australian product and consumer medicine information, up-to-date PBS restrictions and pricing and a drug interactions database.

It also has additional links to TGA safety bulletins, NPS RADAR and NPS medicines update articles, and will be updated automatically on the first of each month.

The new Product Identification module (pictured) includes the ability to search by shape, form, colour, scoring, marking or symbols or search by therapeutic class, company, brand name or generic.

The product size has also been added to the descriptions, which MIMS said was something that has long been requested by customers.

Users who prefer to install eMIMS locally will be able to do so through eMIMSDesktop, which will be released later this year.

It is only available to Windows users and the installation files can be supplied either on DVD or downloadable from the MIMS website.

MIMS country manager Siobhan Murphy said a modern interface and simple functionality is shared across both delivery platforms as is the resource-rich content. What differs is simply the way MIMS delivers each version, she said.

“Because we understand that many of our customers are not yet ready to use an internet-based resource we made a decision to support that thinking and have developed the new eMIMS as both an internet-based and a desktop version,” Ms Murphy said.

Also available as an additional module in the new eMIMS is the IMgateway herb-drug, supplement-drug and food-drug interactions database. Published by UnityHealth, the IMgateway, which recently won the health category in the iAwards, houses over 650 interactions and now includes drug interactions with traditional Chinese medicines and Japanese Kampo medicines.

UnityHealth CEO Peter De Lorenzo said that according to the evidence, some complementary medicines and foods can make some prescription drugs less effective and may cause adverse events.

“Through IMgateway in eMIMS, healthcare professionals will find information is unbiased, rigorous and uniquely available at the point of care helping healthcare professionals provide trusted and relevant advice,” Mr De Lorenzo said.

Posted in Allied Health

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2022 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit